Young Men's Myocarditis Risk 5 Times Higher With Moderna vs Pfizer Vax - Medpage Today

But Canadian study finds that 8-week interval before second dose attenuates some of the risk

Risk of heart inflammation following the second dose of an mRNA COVID-19 vaccine was substantially higher in younger men with Moderna's product (Spikevax) versus Pfizer/BioNTech's (Comirnaty), though… [+5001 chars]

full article...